Pharmalot… Pharmalittle… Morning Edition
Make a commentBy Ed Silverman // October 27th, 2009 // 7:06 am
Good morning, everyone. Nice to see you again. The rain clouds are hovering over the Pharmalot corporate campus, but our spirits are sunny. And why not? We are here to enjoy another day and that counts for a lot. So while we reach for another cup of stimulation, here are some of the latest items to help you on your way. Hope your day is swell…
FDA Approves Glaxo & Genmab Leukemia Drug (Reuters)
ZymoGenetics Gets $70M For Starting Hep C Study (Associated Press)
Arena Tries To Position Its Obesity Pill (Xconomy.com)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Arena Pharmaceuticals, Bristol Myers Squibb, Genmab, GlaxoSmithKline, Hepatitis C, Leukemia, Obesity, ZymoGenetics